Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4–10 ng ml(−1)

Despite its widespread use for prostate cancer screening, low specificity makes PSA a suboptimal biomarker, especially in the diagnostic “gray zone” of 4–10 ng ml(−1). False-positives lead to unnecessary biopsies with attendant morbidities. This is the first prospective validation study of %p2PSA an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Lincoln GL, Tan, Yung Khan, Tai, Bee Choo, Tan, Karen ML, Gauhar, Vineet, Tiong, Ho Yee, Hawkins, Robert CW, Thamboo, Thomas P, Hong, Felicia SK, Chiong, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427782/
https://www.ncbi.nlm.nih.gov/pubmed/26908062
http://dx.doi.org/10.4103/1008-682X.168687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427782/
https://www.ncbi.nlm.nih.gov/pubmed/26908062
http://dx.doi.org/10.4103/1008-682X.168687

Ejemplares similares